Form 4: AbbVie Director Edward J. Rapp Reports Acquisition of Stock Equivalent Units

Director Edward J. Rapp reports acquiring stock equivalent units in AbbVie Inc. due to director fees and dividend reinvestment.

Summary

• Edward J. Rapp, a director of AbbVie Inc., reported a transaction on December 31, 2024.
• Rapp acquired 182 stock equivalent units at a price of $177.7.
• These units were obtained as director fees credited to a stock equivalent unit account under a grantor trust.
• The units earn the same return as if the fees were invested in AbbVie stock and are generally paid in cash at age 65 or upon retirement from the board.
• The balance of stock equivalent units beneficially owned following the reported transaction is 26,976, which includes units acquired through dividend reinvestment.
• The reporting person directly owns the stock equivalent units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation practices and alignment with shareholder interests.

Future Outlook

The stock equivalent units will be paid in cash generally at age 65 or upon retirement from the board.

Industry Context

This filing is a routine disclosure of a director's acquisition of stock equivalent units, which is a common form of compensation for board members. It reflects ongoing alignment of director interests with shareholder value.

Stakeholder Impact

• The transaction aligns the director's interests with those of the shareholders.

Key Dates